Tagged in

colorectal cancer

ColoProg becomes OncoProg

Oxford Cancer Biomarkers are pleased to announce the rebranding of our ColoProg ® product to OncoProg ®   OXFORD, UK

Read More

Colorectal cancer in the Covid-19 era

Professors David and Rachel Kerr’s proposed colorectal cancer treatment guidelines for patients during the COVID-19 era. AIMS To reduce the

Read More

OCB Backing UK’s Artificial Intelligence Revolution

Press Release Oxford Cancer Biomarkers, Tuesday 6th November 2018. OCB is pleased to announce that it is an SME partner

Read More

Should You Be Worried About Rectal Bleeding?

What is rectal bleeding? Rectal bleeding (bleeding from the bottom) is common. In fact, one in four people will experience

Read More

Cancer Survivorship: Tackling the Long-Term Side Effects of Treatment

One in two of us will be diagnosed with some form of cancer in our lives. The good news is

Read More